Structural and functional consequences of succinate dehydrogenase subunit B mutations

Endocrine-Related Cancer

Volumn 22, Issue 3, 2015, Pages 387-397

  Kim, E ^a   Rath, E M ^a   Tsang, V H M ^a,b   Duff, A P ^c   Robinson, B G ^a,b   Church, W B ^a   Benn, D E ^a   Dwight, T ^a   Clifton Bligh, R J ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Functional consequences; Paraganglioma; Phaeochromocytoma; SDHB; Succinate dehydrogenase

Indexed keywords

MITOCHONDRIAL PROTEIN; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT B; UNCLASSIFIED DRUG; SDHB PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; EXPRESSION VECTOR; FUNCTIONAL ASSESSMENT; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENE STRUCTURE; GENETIC CODE; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MISSENSE MUTATION; MOLECULAR DYNAMICS; NONHUMAN; NONSENSE MUTATION; PIG; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; ADRENAL TUMOR; CELL CULTURE TECHNIQUE; CHEMICAL STRUCTURE; CHEMISTRY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; HEK293 CELL LINE; METABOLISM; MITOCHONDRION; MUTATION; PARAGANGLIOMA; PATHOLOGY; PHEOCHROMOCYTOMA; PROTEIN SECONDARY STRUCTURE;

ADRENAL GLAND NEOPLASMS; CELL CULTURE TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; MITOCHONDRIA; MODELS, MOLECULAR; MUTATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PROTEIN STRUCTURE, SECONDARY; SUCCINATE DEHYDROGENASE; TRANSFECTION;

EID: 84937038780     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-15-0099     Document Type: Article

References (48)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS & Sunyaev SR 2010 A method of server for predicting damaging missense mutations. Nature Methods 7 248-249. (doi:10.1038/nmeth0410-248)
2. Amar L, Bertherat J, Baudin E, Ajzenberg C, Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A et al. 2005 Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology 23 8812-8818. (doi:10.1200/JCO.2005.03.1484)
3. Balabin IA, Hu X & Beratan DN 2012 Exploring biological electron transfer pathway dynamics with the Pathways plugin for VMD. Journal of Computational Chemistry 33 906-910. (doi:10.1002/jcc.22927)
4. Barrientos A 2003 Yeast models of human mitochondrial diseases. International Union of Biochemistry and Molecular Biology 55 83-95. (doi:10.1002/tbmb.718540876)
5. Bayley J, Devilee P & Taschner PE 2005 The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.BMCMedicalGenetics 639-45. (doi:10.1186/1471-2350-6-39)
6. Benn DE, Gimenez-Roqueplo AP, Reilly JR, Bertherat J, Burgess J, Byth K, Croxson M, Dahia PL, Elston M, Gimm O et al. 2006 Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. Journal of Clinical Endocrinology and Metabolism 91 827-836. (doi:10.1210/jc.2005-1862)
7. Beratan DN, Betts JN & Onuchic JN 1991 Protein electron transfer rates set by the bridging secondary and tertiary structure. Science 252 1285-1288. (doi:10.1126/science.1656523)
8. Berman H, Henrick K & Nakamura H 2000 Announcing the worldwide Protein Data Bank. Nature Structural & Molecular Biology 10 980. (doi:10.1038/nsb1203-980)
9. Castro-Vega LJ, Buffet A, DeCubasAA, CasconA, MenaraM, Khalifa E, AmarL, Azriel S, Bourdeau I, ChabreOet al. 2014 Germlinemutations inFHconfer predisposition to malignant pheochromocytomas and paragangliomas. Human Molecular Genetics 23 2440-2446. (doi:10.1093/hmg/ddt639)
10. Dahia PL 2014 Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nature Reviews. Cancer 14 108-119. (doi:10.1038/nrc3648)
11. Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS et al. 2005 A HIF1a regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genetics 1 72-80. (doi:10.1371/journal.pgen.0010008)
12. DeLano WL 2002 The PyMOL Molecular Graphics System (DeLano Scientific LLC, San Carlos, CA, USA, http://www.pymol.org).
13. Denko NC 2008 Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nature Reviews. Cancer 8 705-713. (doi:10.1038/nrc2468)
14. Dwight T, Benn DE, Clarkson A, Vilain R, Lipton L, Robinson BG, Clifton-Bligh RJ & Gill AJ 2013 Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors. American Journal of Surgical Pathology 37 226-233. (doi:10.1097/PAS.0b013e3182671155)
15. EswarN, Webb B, Marti-RemonMA, MadhusudhanMS, EramianD, ShenMY, Pieper U & Sali A 2006 Comparative protein structure modeling using Modeller. Current Protocols in Bioinformatics 15 5.6.1-5.6.30. (doi:10.1002/0471250953.bi0506s15)
16. Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF & den Dunnen JT 2011 LOVD v.2.0: the next generation in gene variant databases. Human Mutation 32 557-563. (doi:10.1002/humu.21438)
17. Gill AJ, Chou A, Vilain R, Clarkson A, Lui M, Jin R, Tobias V, Samra J, Goldstein D, Smith RC et al. 2010 Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. American Journal of Surgical Pathology 34 636-644. (doi:10.1097/PAS.0b013e3181d6150d)
18. Gill AJ, Pachter NS, Chou A, Young B, Clarkson A, Tucker KM, Winship IM, Earls P, Benn DE, Robinson BG et al. 2011 Renal tumors associated with germline SDHB mutation show distinctive morphology. American Journal of Surgical Pathology 35 1578-1585. (doi:10.1097/PAS.0b013e318227e7f4)
19. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad J, Plouin P, Corvol P, Rotig A & Jeunemaitre X 2001 The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. American Journal of Human Genetics 69 1186-1197. (doi:10.1086/324413)
20. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rötig A & Jeunemaitre X 2002 Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 87 4771-4774. (doi:10.1210/jc. 2002-020525)
21. Gimenez-Roqueplo AP, Dahia PL & Robledo M 2012 An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Hormone and Metabolic Research 44 328-333. (doi:10.1055/s-0031-1301302)
22. Goffrini P, Ercolino T, Panizza E, GiachèV, Cavone L, Chiarugi A, Dima V, Ferror I & MannelliM2009 Functional study in a yeast model of a novel succinate dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor. Human Molecular Genetics 18 1860-1868. (doi:10.1093/hmg/ddp102)
23. Horvath R, Abicht A, Holinski-Feder E, Laner A, Gempel K, Prokisch H & JakschM2006 Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). Journal of Neurology, Neurosurgery, and Psychiatry 77 74-76. (doi:10.1136/jnnp.2005.067041)
24. Humphrey W, Dalke A & Schulten K 1996 VMD: visual molecular dynamics. Journal of Molecular Graphics 14 33-38. (doi:10.1016/0263-7855(96)00018-5)
25. Imperiale A, Moussallieh FM, Sebag F, Brunaud L, Barlier A, Elbayed K, Bachellier P, Goichot B, Pacak K, Namer IJ et al. 2013 A new specific succinate-glutamate metabolomic hallmark in Sdhx-related paragangliomas. PLoS ONE 8 e80539. (doi:10.1371/journal.pone.0080539)
26. Iverson TM, Maklashina E & Cecchini G 2012 Structural basis for malfunction in complex II. Journal of Biological Chemistry 287 35430-35438. (doi:10.1074/jbc.R112.408419)
27. Jochmanová I, Zelinka T, Widimský J & Pacak K 2014 HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors. Physiological Research 63 S251-S262.
28. Kirby DM, Thorburn DR, TurnbullDM& Taylor RW2007 Biochemical assays of respiratory chain complex activity. Methods in Cell Biology 80 93-119. (doi:10.1016/S0091-679X(06)80004-X)
29. Lane DJ, Merlot AM & Richardson DR 2014 The lure of a LYR: the logistics of iron sulfur cluster delivery. Cell Metabolism 19 348-350. (doi:10.1016/j.cmet.2014.02.011)
30. Lenders J, DuhQY, EisenhoferG, Gimenez-RoqueploAP, Grebe S, MuradMH, Naruse M, Pacak K & Young W 2014 Pheochromocytoma and paraganglioma: an endocrine clnincal practice guideline. Journal of Clinical Endocrinology and Metabolism 99 1915-1945. (doi:10.1210/jc.2014-1498)
31. Lima J, Feijao T, Ferreira da Silva A, Pereira-Castro I, Fernandez-Ballester G, Máximo V & Garcia-Rostan G 2007 High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. Journal of Clinical Endocrinology and Metabolism 92 4853-4864. (doi:10.1210/jc.2007-0640)
32. Lorenzo FR, Yang C, Ng Tang Fui M, Vankayalapati H, Zhuang Z, Huynh T, GrossmannM, Pacak K & Prchal JT 2013 A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma. Journal of Molecular Medicine 91 507-512. (doi:10.1007/s00109-012-0967-z)
33. Maio N, Singh A, Uhrigshardt H, Saxena N, Tong WH & Rouault TA 2014 Cochaperone binding to LYR motifs confers specificity of iron sulfur cluster delivery. Cell Metabolism 19 445-457. (doi:10.1016/j.cmet.2014.01.015)
34. McDonald IK & Thornton JM 1994 Satisfying hydrogen bonding potential in proteins. Journal of Molecular Biology 238 777-793. (doi:10.1006/jmbi.1994.1334)
35. Na U, Yu W, Cox J, Bricker DK, Brockmann K, Rutter J, Thummel CS & Winge DR 2014 The LYR factors SDHAF1 and SDHAF3 mediate maturation of the iron-sulfur subunit of succinate dehydrogenase. Cell Metabolism 20 253-266. (doi:10.1016/j.cmet.2014.05.014)
36. Ng PC & Henikoff S 2001 Predicting deleterious amino acid substitutions. Genome Research 11 863-874. (doi:10.1101/gr.176601)
37. Panizza E, Ercolino T, Mori L, Rapizzi E, Castellano M, Opocher G, Ferrero I, Neumann HP, MannelliM& Goffrini P 2013 Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. Human Molecular Genetics 22 804-815. (doi:10.1093/hmg/dds487)
38. Poliakov E, Managadze D & Rogozin I 2014 Generalized portrait of cancer metabolic pathways inferred froma list of genes overexpressed in cancer. Genetics Research International 646193 1-8. (doi:10.1155/2014/646193)
39. Richter S, PeitzschM, Rapizzi E, Lenders J, Qin N, de Cubas A & Eisenhofer G 2014 Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. Journal of Clinical Endocrinology and Metabolism 99 3903-3911. (doi:10.1210/jc.2014-2151)
40. Šali A & Blundell TL 1993 Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology 234 779-815. (doi:10.1006/jmbi.1993.1626)
41. SelakMA, ArmourSM, MackenzieED, BoulahbelH, WatsonDG, MansfieldKD, Pan Y, SimonMC, Thompson CB& Gottlieb E 2005 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-a prolyl hydroxylase. Cancer Cell 7 77-85. (doi:10.1016/j.ccr.2004.11.022)
42. Srirangalingam U, Walker L, Khoo B, MacDonald F, Gardner D, Wilkin T, Skelly R, George E, Spponer D, Chew SL et al. 2008 Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers. Clinical Endocrinology 69 587-596. (doi:10.1111/j.1365-2265.2008.03274.x)
43. Sun F, Huo X, Zhai Y, Wang A, Xu J, Su D, Bartlam M & Rao Z 2005 Crystal structure of mitochondrial respiratory membrane protein complex II. Cell 121 1043-1057. (doi:10.1016/j.cell.2005.05.025)
44. Van Vranken JG, Na U, Winge DR & Rutter J 2014 Protein-mediated assembly of succinate dehydrogenase and its cofactors. Critical Reviews in Biochemistry and Molecular Biology 9 1-13. (doi:10.3109/10409238.2014.990556)
45. Vicha A, Taieb D & Pacak K 2014 Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma. Endocrine-Related Cancer 21 261-277. (doi:10.1530/ERC-13-0398)
46. Wallace AC, Laskowski RA & Thornton JM 1995 LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Engineering, Design & Selection 8 127-134. (doi:10.1093/protein/8.2.127)
47. Werth MT, Cecchini G, Manodori A, Ackrell BA, Schröder I, Gunsalus RP & Johnson MK 1990 Site-directed mutagenesis of conserved cysteine residues in Escherichia coli fumarate reductase: modification of the spectroscopic and electrochemical properties of the [2Fe-2S] cluster. PNAS 87 8965-8969. (doi:10.1073/pnas.87.22.8965)
48. YangC, Matro JC, HuntoonKM, Donald YY, Huynh YT, Fliedner SM, Breza J, Zhuang Z & Pacak K 2012 Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function. FASEB Journal 26 4506-4516. (doi:10.1096/fj.12-210146)